Assenagon Asset Management S.A. bought a new stake in MAXIMUS, Inc. (NYSE:MMS) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 16,538 shares of the health services provider’s stock, valued at approximately $1,076,000.
Several other hedge funds also recently bought and sold shares of the company. BlackRock Inc. lifted its holdings in shares of MAXIMUS by 6.5% in the 2nd quarter. BlackRock Inc. now owns 7,298,102 shares of the health services provider’s stock worth $453,284,000 after purchasing an additional 445,353 shares during the last quarter. Victory Capital Management Inc. increased its position in MAXIMUS by 8.4% in the 2nd quarter. Victory Capital Management Inc. now owns 3,673,807 shares of the health services provider’s stock valued at $228,181,000 after acquiring an additional 284,846 shares during the period. Van Berkom & Associates Inc. increased its position in MAXIMUS by 14.5% in the 2nd quarter. Van Berkom & Associates Inc. now owns 1,375,401 shares of the health services provider’s stock valued at $85,426,000 after acquiring an additional 174,578 shares during the period. Northern Trust Corp increased its position in MAXIMUS by 1.8% in the 2nd quarter. Northern Trust Corp now owns 1,123,555 shares of the health services provider’s stock valued at $69,785,000 after acquiring an additional 20,408 shares during the period. Finally, Thompson Siegel & Walmsley LLC increased its position in MAXIMUS by 54.5% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 979,701 shares of the health services provider’s stock valued at $60,849,000 after acquiring an additional 345,555 shares during the period. Institutional investors and hedge funds own 93.29% of the company’s stock.
Several analysts recently commented on MMS shares. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Friday, November 23rd. ValuEngine upgraded MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Canaccord Genuity lifted their price target on MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research report on Wednesday, October 10th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $72.00.
Shares of NYSE MMS traded up $0.72 during mid-day trading on Monday, reaching $71.84. The company had a trading volume of 405,600 shares, compared to its average volume of 395,245. The stock has a market capitalization of $4.56 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 1.94 and a beta of 1.02. MAXIMUS, Inc. has a 1-year low of $60.00 and a 1-year high of $72.71.
MAXIMUS (NYSE:MMS) last issued its earnings results on Tuesday, November 20th. The health services provider reported $0.71 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). The company had revenue of $558.50 million during the quarter, compared to analyst estimates of $587.58 million. MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. The business’s revenue was down 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.81 earnings per share. As a group, sell-side analysts expect that MAXIMUS, Inc. will post 3.66 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, November 30th. Stockholders of record on Thursday, November 15th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend was Wednesday, November 14th. This is a boost from MAXIMUS’s previous quarterly dividend of $0.05. MAXIMUS’s dividend payout ratio (DPR) is 29.41%.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Read More: Diversification
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.